:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Paola Defilippi, Francesca Nigrelli, Pietro Arina, Daniela Taverna, Vincenzo Salemme
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	The Journal of Pathology
Online Access:	https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6418
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer
by: Hnin‐Wint‐Wint Swe, et al.
Published: (2024)

Cancer‐associated fibroblast subtypes in the tumor microenvironment of prostate cancer and associations to patient outcomes
by: Marcus Lunau Blanke, et al.
Published: (2026)

Combined use of immunoreactivities of Efp and ZCCHC3 for predicting prognosis of patients with triple‐negative breast cancer
by: Akihiro Fujimoto, et al.
Published: (2025)

Mitochondrial reprogramming in lung cancer: a therapeutic vulnerability and a strategy for reversing drug resistance
by: Woo Hyun Park
Published: (2026)

Recent advances in patient‐derived tumor organoids for reconstructing TME of head and neck cancer
by: Lin Chen, et al.
Published: (2024)

A supratentorial mass in a young adult, with 25 years of follow‐up
by: Francesca Baciorri, et al.
Published: (2024)

Somatic whole exome sequencing of colorectal carcinoma in young patients from sub‐Saharan Africa reveals novel insights
by: Alessandro Pietro Aldera, et al.
Published: (2025)

Immunohistochemistry as a tool for identifying EGFR amplification in CNS tumors
by: Arnault Tauziède‐Espariat, et al.
Published: (2026)

Integrated morphological, immunohistochemical, and genomic profiling identifies uterine leiomyoma patients with hereditary leiomyomatosis and renal cell cancer syndrome: a comprehensive analysis of 252 cases
by: Yan Liu, et al.
Published: (2026)

CRISPR –Cas9 screening identifies the role of FER as a tumor suppressor
by: Jiaqi Wang, et al.
Published: (2024)

NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis
by: Vaibhavi Joshi, et al.
Published: (2024)

AI ‐guided histopathology predicts brain metastasis in lung cancer patients
by: Haowen Zhou, et al.
Published: (2024)

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression
by: Tanjina Kader, et al.
Published: (2025)

Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies
by: Caitlin F Tsang, et al.
Published: (2026)

Clinical outcomes and immune contexture in SMARCA4 ‐deficient gastric cancer patients
by: Mengyao Sun, et al.
Published: (2025)

Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patients
by: Jessica A. Beck, et al.
Published: (2025)

Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study
by: Yongsheng Huang, et al.
Published: (2024)

Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer
by: Xunxi Lu, et al.
Published: (2025)

NAB2::STAT6 fusions and genome‐wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors
by: Kathryn L. Eschbacher, et al.
Published: (2024)

Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma
by: Braydon Meyer, et al.
Published: (2024)

Spatial effects of infiltrating T cells on neighbouring cancer cells and prognosis in stage III CRC patients
by: Mohammadreza Azimi, et al.
Published: (2024)

Topological analysis of the human lymph node reticular network predicts outcome in breast cancer
by: Amy M Llewellyn, et al.
Published: (2026)

Multiple primary dermatofibrosarcoma protuberans tumors in a single patient with chromosomal microarray analysis: A case report and review
by: Joseph S. Durgin, et al.
Published: (2024)

Pan‐cancer evaluation of tumor‐infiltrating lymphocytes and programmed cell death protein ligand‐1 in metastatic biopsies and matched primary tumors
by: Zakhia El Beaino, et al.
Published: (2024)

High chromosomal instability is associated with higher 10‐year risks of recurrence for hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer patients: clinical evidence from a large‐scale, multiple‐site, retrospective study
by: Yu‐Yang Liao, et al.
Published: (2024)

Single‐nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification
by: Silvia González‐Martínez, et al.
Published: (2026)

Functional ex vivoDNA fibre assay to measure replication dynamics in breast cancer tissue
by: Mengting Chen, et al.
Published: (2024)

Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage
by: Max AK Rätze, et al.
Published: (2025)

Hierarchical image pyramid transformer framework for automated breast cancer molecular subtyping using tissue microarrays
by: Baizhou Li, et al.
Published: (2026)

Clinicopathological characteristics of patients with inoperable non‐small cell lung cancer harboring circulating NRF2 pathway mutations
by: Jouni Härkönen, et al.
Published: (2026)

Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2
by: Christina Sharkey, et al.
Published: (2024)

Novel genomic risk stratification model for primary high‐grade malignant peripheral nerve sheath tumor ( MPNST )
by: Hsin‐Yi Chang, et al.
Published: (2026)

Adenocarcinoma of anogenital mammary gland type arising from encapsulated papillary carcinoma: A rare vulvar tumor mimicking breast carcinoma
by: Haiming Tang, et al.
Published: (2024)

Reduced folate receptor alpha ( FOLR1 ) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab‐soravtansine therapy
by: Annika Nasdala, et al.
Published: (2026)

High‐fat diets influence breast cancer progression by modulating CAF‐immune cell interactions through PLAT signaling
by: Weihan Li, et al.
Published: (2025)

A Tc1‐ and Th1‐T‐lymphocyte‐rich tumor microenvironment is a hallmark of MSI colorectal cancer
by: Zhihao Huang, et al.
Published: (2025)

Development of a reference interval for urinary ammonia‐to‐creatinine ratio in feline patients
by: Eleanor E. Brown, et al.
Published: (2024)

Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis
by: Gino Castillo, et al.
Published: (2024)

HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti‐HER‐2/neu (4B5)
by: Yoshiya Horimoto, et al.
Published: (2024)

MicroRNA profiling of testicular Leydig cell tumors identifies a microRNA signature associated with malignancy and miR ‐196b‐5p as a potentially useful biomarker
by: João Lobo, et al.
Published: (2025)